SCHEMBL29735119

SCHEMBL29735119

O=C1c2ccccc2C(=O)N1Cc1n[nH]c(=O)c2c(C(F)(F)F)cc(Br)cc12

nearest known ligand 0.64

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 4/20 0.64
▸ WDR77 Q9BQA1 4/20 0.64
▸ AR P10275 1/20 0.40
▸ ADRA1D P25100 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ ADRA1B P35368 1/20 0.38
▸ PARP1 P09874 1/20 0.36
▸ CYP1B1 Q16678 6/20 0.36
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ENPP1 P22413 2/20 0.34
▸ GRM5 P41594 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23087741 1.00 PRMT5 (0.64) PRMT5WDR77ARADRA1DADRA1A
SCHEMBL23087856 0.84 PRMT5 (0.49) PRMT5WDR77ARADRA1DADRA1A
SCHEMBL29915228 0.84 PRMT5 (0.49) PRMT5WDR77ARADRA1DADRA1A
SCHEMBL23087447 0.84 PRMT5 (0.69) PRMT5WDR77ARPARP1CYP1B1
SCHEMBL29735278 0.84 PRMT5 (0.69) PRMT5WDR77ARPARP1CYP1B1
SCHEMBL23087513 0.83 PRMT5 (0.67) PRMT5WDR77ARPARP1CYP1B1
SCHEMBL29735135 0.83 PRMT5 (0.67) PRMT5WDR77ARPARP1CYP1B1
SCHEMBL29915208 0.83 PRMT5 (0.64) PRMT5WDR77ADRA1DADRA1AADRA1B
SCHEMBL27002267 0.83 PRMT5 (0.64) PRMT5WDR77ADRA1DADRA1AADRA1B
SCHEMBL23087658 0.80 PRMT5 (0.64) PRMT5WDR77ARPARP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4304720-A1 MTA-COOPERATIVE PRMT5 INHIBITORS Mirati Therapeutics, Inc. (US) 2024-01-17 — — EP disclosed
WO-2022192745-A1 MTA-COOPERATIVE PRMT5 INHIBITORS Mirati Therapeutics, Inc. (US) 2022-09-15 — — WO disclosed
EP-4028388-A1 MTA-COOPERATIVE PRMT5 INHIBITORS Mirati Therapeutics, Inc. (US) 2022-07-20 — — EP disclosed
Send feedback